Abstract
Objective To evaluate links between registration and publication across clinical trials led by German university medical centers (UMCs) and registered in either ClinicalTrials.gov or the German Clinical Trials Registry (DRKS). Inadequate links make trial publications and registrations less findable and compromise evidence synthesis and health policy decision making. The World Health Organization (WHO) and others call for better adoption of this straightforward transparency practice.
Design Cross-sectional bibliographic study
Setting German UMC clinical trials
Methods We used automated strategies to download and extract data from trial registries, PubMed, and trial publications for a cohort of all registered, published clinical trials conducted across German UMCs and completed between 2009 and 2017. We implemented regular expressions to detect and classify publication identifiers (DOI and PMID) in registrations, and trial registrations numbers (TRNs) in publication metadata, abstract, and full-text.
Main outcome measures The proportion of trial registrations that reference a known results publication. The proportion of results publications that report the known TRN in the metadata, abstract, and full-text.
Secondary analyses We constructed exploratory logistic regression models to investigate the relationship between trial completion date, registry, and registration-publication linking.
Results Only 20% (373/1,895) of trials have a linked publication (DOI or PMID) in the registration as well as the TRN in the publication full-text, abstract, and metadata, and only 25% (477) of trials met the CONSORT and ICMJE guidelines to include TRNs in both the full-text and the abstract. 17% (327) of trials had no links. The most common link was TRN reported in the full-text (60%, 1,137). ClinicalTrials.gov trials were overall better linked than DRKS trials, and this difference appears to be driven by PubMed and registry infrastructure, rather than by trialists. Of trials reporting a TRN in the abstract, trials in ClinicalTrials.gov were more likely than trials in DRKS to have the TRN captured in the PubMed metadata. Most (78%, 662/849) ClinicalTrials.gov registrations with a publication link were automatically indexed from PubMed metadata, which is not possible in DRKS.
Conclusion German UMCs have not comprehensively linked trial registrations and publications by both including a structured reference to the publication in the registration, and reporting TRNs in results publications. In addition to improved linking by trialists, changes in the PubMed TRN capturing process (such as automated strategies like those developed in this study) and automated indexing of publications in DRKS would make trial registrations and results more findable.
Open Data and Code All code and the final analysis data for this study are available at https://github.com/maia-sh/reg-pub-link. Raw data is available at https://github.com/maia-sh/intovalue-data.
Competing Interest Statement
MSH, BGC, and DS declare they have no direct conflict of interest related to this work. MSH is employed as a researcher under the project funding and additional grants from the German Bundesministerium fuer Bildung und Forschung (BMBF). DS is a member of the Sanofi Advisory Bioethics Committee and receives an honorarium for his contribution to meetings.
Funding Statement
This work was funded under a grant from the Federal Ministry of Education and Research of Germany (Bundesministerium fuer Bildung und Forschung - BMBF) [01PW18012]. The funder had no involvement in the study design, data collection, analysis, or interpretation, writing of the manuscript, or the decision to submit for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos